Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

NCT02732704 is registered in ClinicalTrials.gov with JenaValve Technology, Inc. as lead sponsor.

NCT NCT02732704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02732704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
Lead sponsor
JenaValve Technology, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 20, 2018
Completion date
September 29, 2027
Enrollment
100 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation